Lasa Supergenerics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Lasa Supergenerics Ltd. on BSE

Load latest

Lasa Supergenerics Ltd.

14 Nov 2024

17.60

2.92%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome For The Board Meeting For …

BSE India

Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 01.30 p.m. and concluded at 06.15 p.m. inter- alia have considered and approved the following: 1. The statement of unaudited Financial Results of the Company for the quarter and half year ended on September 30, 2024. 2. Limited Review Report from Statutory Auditor for the quarter ended on September 30, 2024.

pdf

Lasa Supergenerics Ltd.

13 Nov 2024

17.60

2.92%

Company Update

Lasa Supergenerics Ltd - 540702 - Intimation Under Regulation 30 Of SEBI (Listing Obligation And Disclosure …

BSE India

As pronounced by hon''ble NCLT Mumbai bench today 13-11-2024 , we wish to inform you that insolvency application which was filed by financial creditor Bank of Baroda against the Company stands disposed stands disposed of pursuant to withdrawal of application by financial creditor due to concluded settlement between the parties

pdf

Lasa Supergenerics Ltd.

13 Nov 2024

17.60

2.92%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release titled " Successful withdrawal of application under section 7 if I & B, 2016 filed against the Company by financial Creditor" issued by the Company

pdf

Lasa Supergenerics Ltd.

06 Nov 2024

17.60

2.92%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for The Quarter And Half Year Ended …

BSE India

Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve 1. To consider, approve and take on records unaudited financial results of the Company along with the Limited Review Report for the quarter and half year ended on September 30, 2024. 2. To discuss any other matter with the permission of the Chairperson. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct, the Trading Window shall continue to remain closed till 48 hours after the declaration of the unaudited financial results of the Company for the quarter and half year ended September 30, 2024. This Intimation is also available on the company's website at www.lasalabs.com and on the website of the stock Exchange at www.bseindia.com and www.nseindia.com .

pdf

Lasa Supergenerics Ltd.

16 Oct 2024

17.60

2.92%

Company Update

Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certifcate under Reg 74 (5) of SEBI (DP) Reulations 2018, for quarter and half year ended September 30, 2024 received for Bigshare Services Private Limited Regsitrar and share transfer agent of the Company.

pdf

Lasa Supergenerics Ltd.

14 Oct 2024

17.60

2.92%

Company Update

Lasa Supergenerics Ltd - 540702 - Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015

BSE India

We are pleased to inform you that Long Pending Dispute of the company with Bank of Baroda for alleged ECB dues is finally settled and entire settled amount against concluded settled sanction has been paid by the company, with this settlement company has formally achieved its vision of becoming debt free company, as on date company does not have any financial creditor, we have also formally received NO DUES CERTIFICATE from Bank of Baroda. Further, With respect to our communication dated January 12,2022 for filing of application under section 7 of the IBC, 2016 by Bank of Baroda against the company, The counsels / Legal Team are informed for moving necessary application before court for withdrawal of all the Legal Proceedings pertaining to ECB Facility in the name of Lasa Supergenerics Ltd from Bank of Baroda.

pdf

Lasa Supergenerics Ltd.

30 Sep 2024

17.60

2.92%

AGM

Lasa Supergenerics Ltd - 540702 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

In terms of the subject referred, the details regarding consolidated voting results of the business transacted at the 9th AGM of the Company held on Friday, September 27, 2024 is annexed herewith for your reference and records.

pdf

Lasa Supergenerics Ltd.

30 Sep 2024

17.60

2.92%

SAST

Lasa Supergenerics Ltd - 540702 - Closure of Trading Window

BSE India

This is to inform you that as per Company''s Code of Conduct for regulating, monitoring and reporting of trading insiders in terms of (Prohibition of Insider Trading ) Regulations, 2015, as amended, the trading window for dealing in equity shares of the Company has been closed for designated employees and their immediate relatives w.e.f. October 01, 2024 till 48 hours after declaration of unaudited financial results (both inclusive days) for the quarter and half year ended September 30, 2024

pdf

Lasa Supergenerics Ltd.

27 Sep 2024

17.60

2.92%

AGM

Lasa Supergenerics Ltd - 540702 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Pursuant to regulation of SEBI (LODR) Regulations, 2015, as amneded , we arre submitting herewith the summary of proceedings of the 9th AGM of the Company held on Friday 27th September, 2024 at 9.30 AM and concluded at 9.47 AM through Video Conferencing / other audio visual means (VC/OAVM)

pdf

Lasa Supergenerics Ltd.

13 Sep 2024

17.60

2.92%

Company Update

Lasa Supergenerics Ltd - 540702 - Intimiation Under Regulation 30 Of SEBI (LODR), Regulation, 2015 For …

BSE India

Pursuant to Reg 30 of SEBI (LODR) Regulations 2015, We are pleased to inform you that the company has been granted patent by controller of Patent, for invention of " process for preparation and purification of 5- Chloro-2-Nitroaniline" on the 11th day of September , 2024 for the term of 20 years effective from 19th June 2020 in accordance with provisions of patent Act, 1970

pdf

Is Lasa Supergenerics Ltd. worth buying?

50 Votes:

Buy 76.0%

Sell 18.0%

Hold 6.0%